Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lacrimal gland mucous membrane surface refers to the epithelial lining and associated secretions of the lacrimal gland, which contribute to the lubrication, protection, and nourishment of the ocular surface. This surface is crucial for maintaining tear film stability and preventing dry eye disease. Key components include membrane-associated mucins (MUC1, MUC4, MUC16) and secreted mucins (MUC5B, MUC7), along with aqueous tear fluid containing electrolytes, proteins, immunoglobulins, and growth factors. Dysfunction can lead to impaired lubrication and potential vision loss.
Enhancing tear film production and/or mucin secretion; Reducing inflammation and protecting the ocular surface.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lacrimal Gland Mucous Membrane Surface.